8 Sept - Investor-Only Syndication WorkshopMonday, 8 September 2025 - SGT / Singapore

Setting the stage by examining how Asia's biotech investment landscape is rapidly evolving, with syndication emerging as a critical tool to pool capital, mitigate risk, and foster cross-border collaboration. Expect macro-trends, data-driven insights, and a vision for the decade ahead.

• The evolving landscape of biotech investment in Asia
• How syndication is unlocking capital and de-risking investments
• The rise of cross-border funding collaborations

A practical deep-dive into the mechanics of biotech syndicates, featuring investors and founders who've navigated successful deals. Learn how to structure win-win partnerships, align diverse stakeholders, and avoid common pitfalls.

• Advantages of syndicate investing in biotech
• Best practices for structuring investor syndicates
• Lessons from successful syndicated funding rounds

A forward-looking debate on how emerging technologies, regulatory shifts, and global capital flows will reshape biotech syndication in Asia.

• Emerging biotech investment trends
• How AI, precision medicine, and novel therapeutics are shifting investor focus
• Predictions for the next decade of syndicate-backed biotech startups